Phase II/III randomized trial of TCH346 in patients with ALS.
Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H, Moore D, Pohlmann H, Sauer D, Silani V, Strong M, Swash M, Vernotica E; TCH346 Study Group.
Miller R, et al.
Neurology. 2007 Aug 21;69(8):776-84. doi: 10.1212/01.wnl.0000269676.07319.09.
Neurology. 2007.
PMID: 17709710
Clinical Trial.